Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Chlamydia trachomatis | sulfite reductase | 0.0094 | 0.1437 | 0.5 |
Brugia malayi | FAD binding domain containing protein | 0.0153 | 0.5968 | 1 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.0153 | 0.5968 | 0.5 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0153 | 0.5968 | 0.5292 |
Brugia malayi | flavodoxin family protein | 0.0153 | 0.5968 | 1 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.0153 | 0.5968 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.0135 | 0.4621 | 0.5 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0153 | 0.5968 | 0.5292 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0153 | 0.5968 | 0.5 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.0153 | 0.5968 | 0.5 |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.0077 | 0.009 | 0.009 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0153 | 0.5968 | 1 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.0153 | 0.5968 | 0.5 |
Trypanosoma cruzi | p450 reductase, putative | 0.0153 | 0.5968 | 0.5 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0153 | 0.5968 | 0.5292 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 1 | 1 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.0135 | 0.4621 | 0.5 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0094 | 0.1437 | 0.1437 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 1 | 1 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0153 | 0.5968 | 0.5 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0076 | 0 | 0.5 |
Echinococcus multilocularis | geminin | 0.0205 | 1 | 1 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0153 | 0.5968 | 0.5292 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0153 | 0.5968 | 0.5968 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0153 | 0.5968 | 0.5 |
Plasmodium falciparum | nitric oxide synthase, putative | 0.0153 | 0.5968 | 0.5 |
Leishmania major | p450 reductase, putative | 0.0153 | 0.5968 | 1 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0153 | 0.5968 | 0.5 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0153 | 0.5968 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0153 | 0.5968 | 1 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0076 | 0 | 0.5 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0153 | 0.5968 | 1 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0153 | 0.5968 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 1.2589 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 7.3753 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 18.3564 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | ||
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.